Rachel Gibson

Research and Development GlaxoSmithKline Pharmaceuticals Ltd Stevenage United Kingdom

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study”.

Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study

The Lancet Neurology(2011)10.1016/s1474-4422(11)70175-2

N/A

0.876DataRank · unranked

343 citations

Michael G. Heckman, Nadine Abahuni, Grazia Annesi, Justin A. Bacon, Soraya Bardien +60 more

Population‐specific frequencies for LRRK2 susceptibility variants in the genetic epidemiology of Parkinson's disease (GEO‐PD) consortium

Movement Disorders(2013)10.1002/mds.25600

N/A

0.538DataRank · unranked

35 citations

Alexandra I. Soto‐Ortolaza, Nadine Abahuni, Grazia Annesi, Justin A. Bacon, Soraya Bardien +65 more